BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19847278)

  • 1. Evaluation of bone marrow in 143 lymphomas: the relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validity.
    El Bolkainy TM; Abo Deif WS; Gouda HM; Mokhtar NM
    J Egypt Natl Canc Inst; 2008 Mar; 20(1):17-30. PubMed ID: 19847278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Utility and prognostic value of PET/CT, bone marrow biopsy and aspirate for detection of bone marrow involvement in diffuse large B-cell lymphoma].
    Jiang XY; Zou DM; Zhang YQ; Wang Z; Zhang W; Zhou DB; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):663-667. PubMed ID: 36709151
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using
    Hao B; Zhao L; Luo NN; Ruan D; Pang YZ; Guo W; Fu H; Guo XY; Luo ZM; Wu J; Chen HJ; Wu H; Sun L
    BMC Cancer; 2018 Nov; 18(1):1192. PubMed ID: 30497426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.
    Merzianu M; Groman A; Hutson A; Cotta C; Brynes RK; Orazi A; Reddy V; Teruya-Feldstein J; Amre R; Balasubramanian M; Brandao G; Cherian S; Courville E; Czuchlewski D; Fan G; Grier D; Hoehn D; Inamdar KV; Juskevicius R; Kaur P; Lazarchick J; Lewis MR; Miles RR; Myers JB; Nasr MR; Qureishi HN; Olteanu H; Robu VG; Salaru G; Vajpayee N; Vos J; Zhang L; Zhang S; Aye L; Brega E; Coad JE; Grantham J; Ivelja S; McKenna R; Sultan K; Wilding G; Hutchison R; Peterson L; Cheney RT
    Am J Clin Pathol; 2018 Oct; 150(5):393-405. PubMed ID: 30052721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
    Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
    Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
    Chen S; Wang S; He K; Ma C; Fu H; Wang H
    Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and histological features of bone marrow involvement in malignant lymphomas.
    Lambertenghi-Deliliers G; Annaloro C; Soligo D; Oriani A; Pozzoli E; Quirici N; Luksch R; Polli EE
    Ann Hematol; 1992 Aug; 65(2):61-5. PubMed ID: 1324741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
    Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E
    Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
    Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA
    Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
    Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
    Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of bone marrow aspiration and biopsy in routine hematology practice.
    Kaur M; Singh Rana AP; Kapoor S; Puri A
    J Clin Diagn Res; 2014 Aug; 8(8):FC13-6. PubMed ID: 25302200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of bone marrow scintigraphy and unilateral bone marrow biopsy in malignant lymphoma.
    Esmaili J; Safaee SR; Sharifian R; Shoeybi S; Gholamrezanezhad A
    Hell J Nucl Med; 2005; 8(2):125-8. PubMed ID: 16142255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
    Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M
    Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders.
    Sah SP; Matutes E; Wotherspoon AC; Morilla R; Catovsky D
    J Clin Pathol; 2003 Feb; 56(2):129-32. PubMed ID: 12560392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of FDG PET/CT Versus Bone Marrow Biopsy in Pediatric Lymphoma.
    Badr S; Kotb M; Elahmadawy MA; Moustafa H
    Clin Nucl Med; 2018 Dec; 43(12):e428-e438. PubMed ID: 30358625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.